Morgan Stanley’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9K | Sell |
13,382
-18,752
| -58% | -$50.3K | ﹤0.01% | 6471 |
|
|
2025
Q1 | $138K | Sell |
32,134
-19,497
| -38% | -$83.4K | ﹤0.01% | 5876 |
|
|
2024
Q4 | $207K | Sell |
51,631
-7,939
| -13% | -$31.8K | ﹤0.01% | 5772 |
|
|
2024
Q3 | $306K | Buy |
59,570
+37,074
| +165% | +$191K | ﹤0.01% | 5598 |
|
|
2024
Q2 | $183K | Buy |
22,496
+3,824
| +20% | +$31.2K | ﹤0.01% | 5722 |
|
|
2024
Q1 | $98.4K | Sell |
18,672
-32,890
| -64% | -$173K | ﹤0.01% | 5996 |
|
|
2023
Q4 | $471K | Buy |
51,562
+34,298
| +199% | +$313K | ﹤0.01% | 5637 |
|
|
2023
Q3 | $151K | Buy |
17,264
+14,236
| +470% | +$124K | ﹤0.01% | 5703 |
|
|
2023
Q2 | $21.2K | Buy |
3,028
+2,428
| +405% | +$17K | ﹤0.01% | 6548 |
|
|
2023
Q1 | $11.7K | Buy |
+600
| New | +$11.7K | ﹤0.01% | 6829 |
|
|
2022
Q4 | – | Sell |
-100
| Closed | -$1K | – | 7942 |
|
|
2022
Q3 | $1K | Sell |
100
-557
| -85% | -$5.57K | ﹤0.01% | 7585 |
|
|
2022
Q2 | $7K | Hold |
657
| – | – | ﹤0.01% | 7324 |
|
|
2022
Q1 | $7K | Hold |
657
| – | – | ﹤0.01% | 7507 |
|
|
2021
Q4 | $7K | Hold |
657
| – | – | ﹤0.01% | 7571 |
|
|
2021
Q3 | $6K | Hold |
657
| – | – | ﹤0.01% | 7452 |
|
|
2021
Q2 | $7K | Hold |
657
| – | – | ﹤0.01% | 7319 |
|
|
2021
Q1 | $7K | Buy |
+657
| New | +$7K | ﹤0.01% | 7038 |
|